tm logo
NEXRONVAQ
Live/Registered
REGISTERED

on 20 Feb 2024

Last Applicant/ Owned by

Rue de l'Institut 89

Rixensart

BE

B-1330

Serial Number

97316774 filed on 17th Mar 2022

Registration Number

7307904 registered on 20th Feb 2024

in the Principal Register

Correspondent Address

Christopher M. Hanes

GSK

410 Blackwell Street

Legal Brand Protection

Durham, NC 27701

Filing Basis

1. intent to use

Disclaimer

NO DATA

NEXRONVAQ

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Mark Details


Serial Number

No 97316774

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84161733

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th Feb 2024REGISTERED-PRINCIPAL REGISTER
20th Feb 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
05th Dec 2023PUBLISHED FOR OPPOSITION
05th Dec 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31st Oct 2023NOTICE OF ALLOWANCE CANCELLED
31st Oct 2023CASE RETURNED TO EXAMINATION
24th Oct 2023ASSIGNED TO PETITION STAFF
24th Oct 2023PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
24th Oct 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY